Neuren Pharmaceuticals Ltd. (NURPF)
14.28
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Neuren Pharmaceuticals Market Cap : 1.810B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.810B |
| October 22, 2026 | 1.810B |
| October 21, 2026 | 1.810B |
| October 20, 2026 | 1.810B |
| October 19, 2026 | 1.810B |
| October 16, 2026 | 1.810B |
| October 15, 2026 | 1.810B |
| October 14, 2026 | 1.810B |
| October 13, 2026 | 1.810B |
| October 12, 2026 | 1.810B |
| October 09, 2026 | 1.810B |
| October 08, 2026 | 1.810B |
| October 07, 2026 | 1.810B |
| October 06, 2026 | 1.810B |
| October 05, 2026 | 1.810B |
| October 02, 2026 | 1.810B |
| October 01, 2026 | 1.767B |
| September 30, 2026 | 1.767B |
| September 29, 2026 | 1.767B |
| September 28, 2026 | 1.767B |
| September 25, 2026 | 1.767B |
| September 24, 2026 | 1.767B |
| September 23, 2026 | 1.767B |
| September 22, 2026 | 1.767B |
| September 21, 2026 | 1.998B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.998B |
| September 17, 2026 | 1.998B |
| September 16, 2026 | 1.998B |
| September 15, 2026 | 1.998B |
| September 14, 2026 | 2.041B |
| September 11, 2026 | 2.041B |
| September 10, 2026 | 2.041B |
| September 09, 2026 | 2.041B |
| September 08, 2026 | 2.041B |
| September 04, 2026 | 2.041B |
| September 03, 2026 | 2.041B |
| September 02, 2026 | 2.041B |
| September 01, 2026 | 2.030B |
| August 31, 2026 | 2.030B |
| August 28, 2026 | 2.059B |
| August 27, 2026 | 2.059B |
| August 26, 2026 | 1.966B |
| August 25, 2026 | 1.966B |
| August 24, 2026 | 1.966B |
| August 21, 2026 | 1.966B |
| August 20, 2026 | 1.964B |
| August 19, 2026 | 1.964B |
| August 18, 2026 | 1.964B |
| August 17, 2026 | 2.052B |
| August 14, 2026 | 2.153B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Percheron Therapeutics Ltd. | 3.654M |
| Starpharma Holdings Ltd. | 151.22M |
| Mayne Pharma Group Ltd. | 147.05M |
| Acrux Ltd. | 3.118M |
| Zelira Therapeutics Ltd. | 3.093M |
Market Cap Related Metrics
| PE Ratio | 138.61 |
| PS Ratio | 39.35 |
| Price to Free Cash Flow | 290.42 |
| Price | 14.28 |
| Earnings Yield | 0.72% |
| Operating PE Ratio | 201.49 |
| Normalized PE Ratio | 115.60 |